Moreover, the patient’s prothrombin time and activated partial thromboplastin time extended packages were not reexamined after 12 weeks of treatment, and it was not clear whether lupus anticoagulants persisted or appeared temporarily. The gene discussed is F2; the disease is systemic lupus erythematosus.